Cas no 91426-39-0 (5-(3'-Hydroxybenzylidene)hydantoin)
5-(3'-Hydroxybenzylidene)hydantoin Chemical and Physical Properties
Names and Identifiers
-
- 5-(3'-Hydroxybenzylidene)hydantoin
- 5-(3′-Hydroxybenzylidene)hydantoin
- (5E)-5-[(3-hydroxyphenyl)methylidene]imidazolidine-2,4-dione
- 5-(3?-Hydroxybenzylidene)hydantoin
- AKOS002952854
- NSC-659449
- MLS000756648
- 91426-39-0
- DTXSID00421014
- NSC659449
- (5E)-5-[(3-hydroxyphenyl)methylene]imidazolidine-2,4-dione
- 2,4-Imidazolidinedione, 5-[(3-hydroxyphenyl)methylene]-
- 5-(3-Hydroxybenzylidene)-2,4-imidazolidinedione
-
- Inchi: 1S/C10H8N2O3/c13-7-3-1-2-6(4-7)5-8-9(14)12-10(15)11-8/h1-5,13H,(H2,11,12,14,15)/b8-5+
- InChI Key: HZAHUPKFCIYWHZ-VMPITWQZSA-N
- SMILES: O=C1/C(=C\C2C=CC=C(C=2)O)/NC(N1)=O
Computed Properties
- Exact Mass: 204.05349212g/mol
- Monoisotopic Mass: 204.05349212g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 3
- Hydrogen Bond Acceptor Count: 3
- Heavy Atom Count: 15
- Rotatable Bond Count: 1
- Complexity: 325
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 1
- Undefined Bond Stereocenter Count: 0
- XLogP3: 0.7
- Topological Polar Surface Area: 78.4?2
Experimental Properties
- Melting Point: 300°C dec.
5-(3'-Hydroxybenzylidene)hydantoin Security Information
- Signal Word:warning
- Hazard Statement: H303May be harmful if swallowed+H313Skin contact may be harmful+H333Inhalation may be harmful to the body
- Warning Statement: P264+P280+P305+P351+P338+P337+P313
- Safety Instruction: H303+H313+H333
- Storage Condition:storage at -4℃ (1-2weeks), longer storage period at -20℃ (1-2years)
5-(3'-Hydroxybenzylidene)hydantoin Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| TRC | H829630-1g |
5-(3'-Hydroxybenzylidene)hydantoin |
91426-39-0 | 1g |
$ 138.00 | 2023-09-07 | ||
| TRC | H829630-10g |
5-(3'-Hydroxybenzylidene)hydantoin |
91426-39-0 | 10g |
$ 1068.00 | 2023-09-07 |
5-(3'-Hydroxybenzylidene)hydantoin Related Literature
-
1. Estimation of hydrogen sulfide from crude petroleum: a unique invention using a simple chemosensor?Shampa Kundu,Prithidipa Sahoo New J. Chem., 2019,43, 12369-12374
-
Max Attwood,Hiroki Akutsu,Lee Martin,Toby J. Blundell,Pierre Le Maguere,Scott S. Turner Dalton Trans., 2021,50, 11843-11851
-
Saeideh Mirfakhraei,Malak Hekmati,Fereshteh Hosseini Eshbala,Hojat Veisi New J. Chem., 2018,42, 1757-1761
-
5. Estimating and correcting interference fringes in infrared spectra in infrared hyperspectral imagingGhazal Azarfar,Ebrahim Aboualizadeh,Nicholas M. Walter,Simona Ratti,Camilla Olivieri,Alessandra Norici,Michael Nasse,Achim Kohler,Mario Giordano Analyst, 2018,143, 4674-4683
Additional information on 5-(3'-Hydroxybenzylidene)hydantoin
Introduction to 5-(3'-Hydroxybenzylidene)hydantoin (CAS No. 91426-39-0)
5-(3'-Hydroxybenzylidene)hydantoin (CAS No. 91426-39-0) is a significant compound in the field of chemical and pharmaceutical research, known for its versatile applications in medicinal chemistry and biotechnology. This compound, characterized by its unique structural framework, has garnered considerable attention due to its potential in various biochemical interactions and therapeutic interventions.
The molecular structure of 5-(3'-Hydroxybenzylidene)hydantoin consists of a benzylidene group attached to a hydantoin core. This configuration imparts distinct chemical properties that make it a valuable intermediate in the synthesis of more complex molecules. The presence of the hydroxyl group on the benzylidene moiety enhances its reactivity, making it particularly useful in organic synthesis and as a precursor for developing novel pharmacological agents.
In recent years, 5-(3'-Hydroxybenzylidene)hydantoin has been extensively studied for its role in developing new drug candidates. Its ability to interact with biological targets has opened up possibilities in treating a range of diseases, including inflammatory conditions and metabolic disorders. The compound's hydantoin core is known for its stability and compatibility with biological systems, which makes it an attractive scaffold for drug design.
One of the most compelling aspects of 5-(3'-Hydroxybenzylidene)hydantoin is its potential in modulating enzyme activity. Researchers have observed that derivatives of this compound can inhibit specific enzymes involved in disease pathways, thereby offering a mechanism for therapeutic intervention. For instance, studies have shown that certain analogs of this molecule exhibit inhibitory effects on kinases and phosphodiesterases, which are key players in cellular signaling cascades.
The hydroxyl group in the benzylidene part of the molecule also plays a crucial role in its pharmacological properties. This functional group allows for further chemical modifications, enabling the synthesis of a diverse array of derivatives with tailored biological activities. Such modifications have led to the development of novel compounds with enhanced efficacy and reduced side effects compared to existing treatments.
Recent advancements in computational chemistry have further accelerated the discovery process for new derivatives of 5-(3'-Hydroxybenzylidene)hydantoin. Molecular modeling techniques have been employed to predict the binding affinities and interactions of various analogs with biological targets. These simulations have provided valuable insights into the structural requirements needed for optimal activity, guiding the design of more effective drug candidates.
In addition to its therapeutic potential, 5-(3'-Hydroxybenzylidene)hydantoin has shown promise in industrial applications. Its stability and reactivity make it suitable for use as a building block in synthesizing fine chemicals and agrochemicals. The compound's ability to undergo selective reactions under mild conditions has also made it an attractive choice for green chemistry initiatives aimed at reducing environmental impact.
The synthesis of 5-(3'-Hydroxybenzylidene)hydantoin involves multi-step organic reactions that highlight its synthetic utility. The process typically begins with the condensation of benzaldehyde derivatives with guanidine hydrochloride, followed by cyclization to form the hydantoin core. Further functionalization can then be performed to introduce additional substituents and enhance biological activity.
Ongoing research continues to explore new applications for 5-(3'-Hydroxybenzylidene)hydantoin. Studies are focusing on its potential use in photodynamic therapy, where its ability to generate reactive oxygen species upon light exposure could be exploited for cancer treatment. Additionally, investigations into its antimicrobial properties are underway, with preliminary results suggesting efficacy against resistant bacterial strains.
The compound's versatility extends to material science as well. Researchers have been experimenting with incorporating 5-(3'-Hydroxybenzylidene)hydantoin into polymer matrices to create novel materials with enhanced mechanical and thermal properties. These materials could find applications in electronics, coatings, and advanced composites.
In conclusion, 5-(3'-Hydroxybenzylidene)hydantoin (CAS No. 91426-39-0) is a multifaceted compound with significant potential across multiple domains of science and industry. Its unique structural features and reactivity make it an invaluable tool for drug discovery, material science, and industrial chemistry. As research continues to uncover new applications and functionalities, this compound is poised to play an increasingly important role in advancing scientific knowledge and technological innovation.
91426-39-0 (5-(3'-Hydroxybenzylidene)hydantoin) Related Products
- 3775-01-7(5-benzylidenehydantoin)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)